Oxidative stress in diabetes – circulating advanced glycation end products, lipid oxidation and vascular disease

Diabetes clinical trials: helped or hindered by the current shift in regulatory requirements?

(2012) F. Zannad et al.   EUROPEAN HEART JOURNAL

Systematic review on the association between F2-isoprostanes and cardiovascular disease

(2012) Z.-J. Zhang   ANNALS OF CLINICAL BIOCHEMISTRY

A comparison of methods for the measurement of 8-isoPGF2 : a marker of oxidative stress

(2011) K. A. Smith et al.   ANNALS OF CLINICAL BIOCHEMISTRY

Oxidative Stress and Diabetic Complications

(2010) Ferdinando Giacco et al.   CIRCULATION RESEARCH

The lipid peroxidation products as possible markers of Alzheimer's disease in blood

(2010) A. Skoumalová et al.   EXPERIMENTAL GERONTOLOGY

Oxidative LDL modification is increased in vascular dementia and is inversely associated with cognitive performance

(2010) L. Li et al.   FREE RADICAL RESEARCH

Oxidative damage to DNA and lipids: correlation with protein glycation in patients with type 1 diabetes

(2010) Mohammad Taghi Goodarzi et al.   JOURNAL OF CLINICAL LABORATORY ANALYSIS

Irreversibly glycated LDL induce oxidative and inflammatory state in human endothelial cells; added effect of high glucose

(2009) Laura Toma et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial

(2009) B. E. de Galan et al.   DIABETOLOGIA

Homocysteine enhances LDL fatty acid peroxidation, promoting microalbuminuria in type 2 diabetes

(2008) A. Kassab et al.   ANNALS OF CLINICAL BIOCHEMISTRY